1. Home
  2. NKTX vs TSE Comparison

NKTX vs TSE Comparison

Compare NKTX & TSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTX
  • TSE
  • Stock Information
  • Founded
  • NKTX 2015
  • TSE 2010
  • Country
  • NKTX United States
  • TSE United States
  • Employees
  • NKTX N/A
  • TSE N/A
  • Industry
  • NKTX Biotechnology: Pharmaceutical Preparations
  • TSE Major Chemicals
  • Sector
  • NKTX Health Care
  • TSE Industrials
  • Exchange
  • NKTX Nasdaq
  • TSE Nasdaq
  • Market Cap
  • NKTX 123.5M
  • TSE 107.7M
  • IPO Year
  • NKTX 2020
  • TSE 2014
  • Fundamental
  • Price
  • NKTX $1.77
  • TSE $3.73
  • Analyst Decision
  • NKTX Strong Buy
  • TSE
  • Analyst Count
  • NKTX 6
  • TSE 0
  • Target Price
  • NKTX $14.40
  • TSE N/A
  • AVG Volume (30 Days)
  • NKTX 422.2K
  • TSE 251.0K
  • Earning Date
  • NKTX 08-12-2025
  • TSE 08-05-2025
  • Dividend Yield
  • NKTX N/A
  • TSE 1.05%
  • EPS Growth
  • NKTX N/A
  • TSE N/A
  • EPS
  • NKTX N/A
  • TSE N/A
  • Revenue
  • NKTX N/A
  • TSE $3,394,000,000.00
  • Revenue This Year
  • NKTX N/A
  • TSE $1.84
  • Revenue Next Year
  • NKTX N/A
  • TSE $4.44
  • P/E Ratio
  • NKTX N/A
  • TSE N/A
  • Revenue Growth
  • NKTX N/A
  • TSE N/A
  • 52 Week Low
  • NKTX $1.31
  • TSE $1.94
  • 52 Week High
  • NKTX $8.23
  • TSE $7.05
  • Technical
  • Relative Strength Index (RSI)
  • NKTX 46.34
  • TSE 66.90
  • Support Level
  • NKTX $1.76
  • TSE $2.92
  • Resistance Level
  • NKTX $2.08
  • TSE $3.85
  • Average True Range (ATR)
  • NKTX 0.11
  • TSE 0.22
  • MACD
  • NKTX -0.00
  • TSE 0.10
  • Stochastic Oscillator
  • NKTX 25.00
  • TSE 87.10

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About TSE Trinseo PLC

Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.

Share on Social Networks: